Gynae BT 2017

L1-CAM

Zeimet et al 2013

Bosse et al 2014

L1-CAM strong negative prognostic factor • About 7-10% overall L1CAM+ • More often L1CAM+ in grade 3, p53+, NEEC • Confirmed in large ENITEC series (n=1200)

Zeimet, JNCI 2013; Bosse, EJC 2014; Van der Putten for ENITEC, Br J Cancer 2016